GCO
Genesco Inc.
GCO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NIO
NIO Inc.
NIO has a slight edge over GCO overall, supported by stronger fundamentals and stronger valuation.
GCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
GCO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
GCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $23.89 | -33% |
| Fair | 7.3x | $28.93 | -19% |
| Current | 9x | $35.78 | — |
| Forward | 12x | $35.78 | — |
| Expensive | 20x | $78.41 | +119% |
Historical ranges are pointers, not guarantees.
GCO's PE is in its expensive range at 9.0x. On analysts' estimates for next year's earnings, today's price would be 12x.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
GCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GCO's earnings to grow and its profitability to improve, with its revenue holding steady.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over GCO on the outlook, with more favorable revenue expectations.
GCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.09 | -22% |
| Q3 2026 | $3.96 | +$6.37 |
| Q2 2026 | $1.85 | +$3.38 |
| Q1 2026 | $1.25 | +$2.99 |
| Q4 2025 | -$0.15 | +$2.46 |
| Q3 2025 | -$2.41 | -$2.16 |
| Q2 2025 | -$1.53 | +$0.60 |
| Q1 2025 | -$1.74 | -$0.24 |
| Q4 2024 | -$2.61 | -$1.87 |
GCO has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
GCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $529.9M | -3% |
| Q2 2026 | $487M | +2.8% |
| Q1 2026 | $799.9M | +7.2% |
| Q4 2025 | $616.2M | +3.3% |
| Q3 2025 | $546M | +4% |
| Q2 2025 | $474M | +3.6% |
| Q1 2025 | $745.9M | +0.9% |
| Q4 2024 | $596.3M | +2.9% |
GCO's revenue grew through 2021 and has held roughly level since: $530M last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +3.3 points |
| Q2 2026 | -3.2% | +2.8 points |
| Q1 2026 | 6.4% | +0.2 points |
| Q4 2025 | 1.4% | -0.3 points |
| Q3 2025 | -2.6% | -0.7 points |
| Q2 2025 | -5.9% | +1.1 points |
| Q1 2025 | 6.2% | +1.1 points |
| Q4 2024 | 1.7% | -0.2 points |
GCO has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over GCO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
GCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60M | -16% |
| Q2 2026 | -$118.2M | +$1.7M |
| Q1 2026 | $163.5M | +58% |
| Q4 2025 | -$31.5M | +$4.7M |
| Q3 2025 | $71.7M | +262% |
| Q2 2025 | -$119.9M | -$79.8M |
| Q1 2025 | $103.3M | -4.2% |
| Q4 2024 | -$36.2M | -$23.4M |
GCO still generates free cash flow, though less than at its 2026 peak: $74M over the past year.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
GCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | 1.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
GCO has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 52.5 | Neutral |
GCO's weekly RSI is 52 (neutral) and its Stochastic is 53 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
GCO PE vs Consumer Cyclical Sector
| Metric | GCO | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 18x | 50% below |
| PE % | 68 | 47 | 21 pts above |
GCO is trading at 9.0x earnings, a 50% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
GCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.2 | 1.1% below |
| 20 week MA | $35.6 | 0.4% above |
| 50 week MA | $32.9 | 8.9% above |
| 100 week MA | $30.9 | 16% above |
| 200 week MA | $30.6 | 17% above |
GCO has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
GCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $27.9 | -42% |
| 2021 | $27.9 | $59.8 | +114% |
| 2022 | $59.8 | $44.2 | -26% |
| 2023 | $44.2 | $35.2 | -20% |
| 2024 | $35.2 | $42.1 | +20% |
| 2025 | $42.1 | $25.6 | -39% |
| 2026 YTD | $25.6 | $35.8 | +40% |
GCO has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.